CDKN2A and cancer: Together, these observations imply that replication-stress-associated genomic destabilization underlies the stepwise progression of cancer development, at least in regard to the clonal evolution of cells that have lost ARF/p53-dependent defense systems and have acquired resistance to the anti-cancer drug CPT [7].